Academic Jobs - Home of Higher Ed Logo

Brain Parasite Kill Switch Discovery: One in Three People Carry Toxoplasma gondii but the Body Has an Immune Defense, New UVA Research Reveals

360views
Submit News
purple and pink water splash
Photo by Jr Korpa on Unsplash

A groundbreaking study from the University of Virginia School of Medicine has uncovered a crucial defense mechanism in the human body against Toxoplasma gondii, a common brain parasite that infects an estimated one in three people worldwide. Researchers led by Tajie Harris, PhD, director of the Center for Brain Immunology and Glia (BIG Center), revealed that this parasite can infiltrate CD8+ T cells—the very immune cells tasked with destroying it—but the body activates a molecular "kill switch" via the enzyme caspase-8 to trigger self-destruction of these infected cells, effectively eliminating the parasite.

This discovery, published in the prestigious journal Science Advances on December 12, 2025, sheds new light on how the immune system maintains lifelong control over T. gondii in healthy individuals, preventing the severe disease toxoplasmosis that plagues immunocompromised patients. With over 40 million Americans carrying the parasite asymptomatically, understanding this kill switch could pave the way for novel treatments and bolster brain immunology research.

Microscopic image of Toxoplasma gondii tachyzoites invading host cells

The Ubiquity of Toxoplasma gondii: A Silent Brain Invader

Toxoplasma gondii (T. gondii) is a single-celled protozoan parasite capable of infecting virtually all warm-blooded animals, including humans. Its complex life cycle involves cats as definitive hosts where sexual reproduction occurs, producing infectious oocysts shed in feces. Humans and other mammals serve as intermediate hosts, acquiring the parasite through ingestion of oocysts from contaminated soil, water, fruits, or vegetables, or via tissue cysts in undercooked meat from infected animals like pigs, sheep, or deer.

Upon infection, T. gondii rapidly disseminates via the bloodstream, invading multiple organs but favoring the brain, muscles, and eyes where it forms latent bradyzoite cysts. These cysts can persist for the host's lifetime, evading full clearance. In the United States, seroprevalence—the proportion of people with antibodies indicating past or current infection—ranges from 11% to 22%, translating to 40-60 million carriers. Globally, the figure approaches one-third of the population, with higher rates in regions with raw meat consumption or poor sanitation.

Most healthy individuals experience mild, flu-like symptoms or none at all during acute infection, as the immune system converts tachyzoites (rapidly dividing forms) into dormant bradyzoites. However, reactivation occurs in immunocompromised states, such as HIV/AIDS, organ transplants, or chemotherapy, leading to encephalitis, retinal damage, or fatal brain inflammation.

UVA's Neuroscience Team and the Science Advances Publication

At the forefront of this research is Tajie H. Harris, an associate professor in the Department of Neuroscience and director of UVA's Center for Brain Immunology and Glia (BIG Center). With a PhD in Microbiology and expertise in neuroimmunology, Harris has pioneered live imaging of immune cells in the living brain, revealing dynamic pathogen-immune interactions. Her lab's latest paper, "Caspase-8 expression in CD8 T cells promotes pathogen restriction in the brain during Toxoplasma gondii infection," details collaborative work with graduate students and postdocs including Lydia A. Sibley, Maureen N. Cowan, Abigail G. Kelly, and others, alongside John R. Lukens.

Funded by multiple National Institutes of Health (NIH) grants totaling over $2.6 million, UVA Pinn Scholars Awards, and internal Strategic Investment Funds, the study exemplifies UVA's commitment to translational neuroscience. All authors are affiliated with UVA, highlighting the university's role in training the next generation of researchers through programs like T32 training grants.Explore research assistant jobs in neuroscience at institutions like UVA via higher ed faculty positions.

"We know that T cells are really important for combatting Toxoplasma gondii... We found that these very T cells can get infected, and, if they do, they can opt to die," Harris explained, emphasizing the sacrificial role of immune cells.

CD8+ T Cells: The Immune System's Cytotoxic Enforcers

Cytotoxic CD8+ T cells, also known as killer T cells, are a subset of adaptive immune cells produced in the bone marrow and matured in the thymus. They recognize viral or intracellular pathogen antigens presented on major histocompatibility complex class I (MHC-I) molecules via their T cell receptors (TCRs). Upon activation by helper signals like interleukin-12 (IL-12) and interferon-gamma (IFN-γ), CD8+ T cells proliferate, release perforin and granzymes to induce apoptosis in infected cells, or express Fas ligand (FasL) to trigger extrinsic death pathways.

  • Perforin forms pores in target cell membranes.
  • Granzymes enter and activate intracellular caspases.
  • FasL binds Fas receptors, recruiting caspase-8.
  • Cytokines like IFN-γ recruit more immune cells and activate microglia.

In chronic T. gondii infection, CD8+ T cells infiltrate the brain, patrolling cyst-laden areas to prevent reactivation—a process termed immune surveillance.

The Parasite's Bold Move: Infecting Its Own Hunters

Contrary to expectations, T. gondii actively invades CD8+ T cells in the brain, as demonstrated using a genetically modified parasite strain (TF-Pru) that labels interacted host cells via Cre-recombinase. In wild-type mice, few CD8+ T cells showed evidence of infection, but in caspase-8 deficient models, infection rates soared, allowing parasite replication within parasitophorous vacuoles.

This invasion likely occurs during T cell motility near cysts, exploiting transient vulnerabilities. However, the parasite's success is short-lived in healthy hosts due to the rapid activation of cell death pathways.

Caspase-8: Decoding the Kill Switch Step-by-Step

Caspase-8 (cysteine-aspartic protease 8) is an initiator caspase central to extrinsic apoptosis. Here's how it functions as the kill switch against T. gondii:

  1. Fas Activation: Infected CD8+ T cells or neighboring cells express FasL, binding Fas death receptors on the T cell surface.
  2. Death-Inducing Signaling Complex (DISC) Formation: Fas recruits FADD (Fas-associated death domain) and procaspase-8.
  3. Caspase-8 Dimerization and Autocleavage: Procaspase-8 homodimerizes, cleaving into active p18/p10 subunits.
  4. Apoptosis Cascade: Active caspase-8 cleaves Bid to tBid, activating mitochondrial Bax/Bak; also directly activates executioner caspase-3/6/7.
  5. Cell Demise: DNA fragmentation, membrane blebbing, and phagocytosis of remnants, destroying the intracellular parasite.

UVA researchers confirmed cleaved caspase-8 in brain CD8+ T cells via immunohistochemistry, absent in knockouts. Caspase-8 also suppresses necroptosis (via RIPK3 inhibition), balancing inflammation.

Diagram of caspase-8 mediated apoptosis pathway in CD8 T cells

Rigorous Experiments: Mouse Models Prove the Mechanism

The study employed sophisticated genetic tools:

  • Global Casp8−/− Ripk3−/− mice: 8-fold higher brain cysts at 4 weeks post-infection (wpi), death by 6 wpi despite elevated IFN-γ+ CD8+ T cells and monocytes.
  • Cell-specific knockouts: Only CD8α Cre Casp8fl/fl mice showed increased burden (2-3 fold at 6-8 wpi), infected CD8+ T cells, and reduced survival; neuron/astrocyte/microglia deletions had no effect.
  • Faslpr mice (Fas deficient): Confirmed pathway dependency.
  • Imaging: MERFISH spatial transcriptomics showed high Casp8 in immune cells; flow cytometry quantified infections.

These findings isolate caspase-8's role in T cells as pivotal for brain protection. Read the full Science Advances paper.

Health Implications: Safeguarding the Vulnerable

For immunocompromised patients—those with HIV (CD4 <100), transplant recipients, or cancer therapies—toxoplasmosis mortality reaches 10-30%. This research elucidates why: impaired T cell apoptosis allows parasite proliferation. Enhancing caspase-8 activity or Fas signaling could offer adjunct therapies alongside pyrimethamine-sulfadiazine.

Pregnant women face congenital risks: 30-40% transmission if acute infection, causing hydrocephalus or chorioretinitis in newborns. Prevention remains key: cook meat to 160°F, freeze at 0°F, wash produce, avoid cat litter.Aspiring researchers can contribute via clinical research jobs.

Behavioral Controversies: Links to Schizophrenia?

Intriguing associations exist between T. gondii and neuropsychiatric disorders. Meta-analyses show infected individuals have 1.5-2x higher schizophrenia risk, possibly via dopamine dysregulation or cyst-induced inflammation. Cat ownership doubles odds in some studies. However, causation remains unproven—confounders like socioeconomic status play roles. UVA's work indirectly informs by highlighting immune-brain interfaces.

Future Directions and UVA's Research Ecosystem

Next steps include human iPSC-derived T cell models, caspase-8 agonists, and imaging infected human brains. UVA's BIG Center fosters interdisciplinary work, with open research assistant jobs. Aspiring academics can rate professors like Harris or pursue postdoc opportunities in immunology.

This publication underscores UVA's excellence in higher education research, attracting top talent amid NIH funding trends. For career advice, visit higher ed career advice.

Prevention and Actionable Insights

  • Cook meats thoroughly; peel/wash produce.
  • Change cat litter daily if at risk; feed commercial food.
  • Pregnant/immunocompromised: test serology, consult providers.
  • Researchers: Explore caspase pathways for broad antimicrobials.

In summary, UVA's kill switch discovery empowers precise interventions, reinforcing the brain's resilience. Stay informed via university jobs in neuroscience.

Portrait of Dr. Nathan Harlow
About the author

Dr. Nathan HarlowView author

Academic Jobs In House Author

Acknowledgements:

Discussion

Sort by:

Be the first to comment on this article!

You

Please keep comments respectful and on-topic.

New0 comments

Join the conversation!

Add your comments now!

Have your say

Engagement level

Browse by Faculty

Browse by Subject

Frequently Asked Questions

🦠What is Toxoplasma gondii?

Toxoplasma gondii is a protozoan parasite infecting one-third of humans via cats, undercooked meat, or produce. It forms brain cysts but is controlled by immunity in healthy people.CDC info.

🔬How does the brain parasite kill switch work?

Caspase-8 triggers apoptosis in infected CD8+ T cells, destroying the parasite inside. UVA mouse models showed knockouts lead to fatal brain overload.

⚠️Who is at risk for severe toxoplasmosis?

Immunocompromised (HIV, transplants) and pregnant women. US: 40M carriers, but acute risks low with prevention.

📚What did UVA researchers discover?

Led by Tajie Harris, PhD, the team proved CD8+ T cell caspase-8 restricts T. gondii in brain. Published Science Advances Dec 2025.

🧠Is there a link to schizophrenia?

Meta-analyses show association (1.5-2x risk), possibly via dopamine changes, but causation unproven. Ongoing research needed.

🛡️How to prevent T. gondii infection?

  • Cook meat to 160°F.
  • Wash produce.
  • Avoid cat litter if pregnant.

⚙️What is caspase-8?

Initiator caspase for extrinsic apoptosis, activated by Fas, leading to cell death and pathogen elimination.

🏫UVA's BIG Center role?

Center for Brain Immunology and Glia directs neuroimmunology, training via NIH T32 grants. Postdoc jobs.

💊Implications for treatments?

Boosting caspase-8/Fas could aid immunocompromised. Current: pyrimethamine + sulfadiazine.

🎓Research careers in this field?

Neuroscience postdocs, faculty at UVA. Check professor jobs, career advice.

📊US prevalence of T. gondii?

40+ million infected; seroprevalence 11-22%. Higher in foreign-born.